A next generation peripherally restricted Cavα2δ-1 ligand with inhibitory action on Cav2.2 channels and utility in neuropathic pain
The Voltage-Gated Calcium Channel (VGCC) auxiliary subunit Cavα2δ-1 (CACNA2D1) is the target/receptor of gabapentinoids which are known therapeutics in epilepsy and neuropathic pain. Following damage to the peripheral sensory nervous system, Cavα2δ-1 is upregulated in dorsal root ganglion (DRG) neur...
Main Authors: | Franz Kricek, Christine Ruf, Premji Meghani, Ivana A. Souza, Maria A. Gandini, Gerald W. Zamponi, George Skouteris |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-05-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332224003561 |
Similar Items
-
Electrophysiological and computational analysis of Cav3.2 channel variants associated with familial trigeminal neuralgia
by: Emilio R. Mustafá, et al.
Published: (2022-11-01) -
Electrophysiological characterization of a Cav3.2 calcium channel missense variant associated with epilepsy and hearing loss
by: Robin N. Stringer, et al.
Published: (2023-09-01) -
BK Potassium Channels Suppress Cavα2δ Subunit Function to Reduce Inflammatory and Neuropathic Pain
by: Fang-Xiong Zhang, et al.
Published: (2018-02-01) -
Clinical and molecular spectrum of P/Q type calcium channel Cav2.1 in epileptic patients
by: Elham Alehabib, et al.
Published: (2021-11-01) -
Splice isoform-specific suppression of the CaV2.1 variant underlying spinocerebellar ataxia type 6
by: Wei-Ling Tsou, et al.
Published: (2011-09-01)